Abstract:Cationic antimicrobial peptides have attracted increasing attention as a novel class of antibiotics to treat infectious diseases caused by pathogenic bacteria. However, susceptibility to protease is a shortcoming in their development. Cyclization is one approach to increase the proteolytic resistance of peptides. Therefore, to improve the proteolytic resistance of Polybia-MPI, we have synthesized the MPI cyclic analogs C-MPI-1 (i-to-i+4) and C-MPI-2 (i-to-i+6) by copper(I)-catalyzed azide-alkyne cycloaddition. Compared with MPI, C-MPI-1 displayed sustained antimicrobial activity and had enhanced anti-trypsin resistance, while C-MPI-2 displayed no antimicrobial activity. The relationship between peptide structure and bioactivity was further investigated by probing the secondary structure of the peptides by circular dichroism. This showed that C-MPI-1 adopted an a-helical structure in aqueous solution and, interestingly, had increased a-helical conformation in 30 mM sodium dodecyl sulfate and 50% trifluoroethyl alcohol compared with MPI. C-MPI-2 that was not a-helical in structure, suggesting that the propensity for a-helix conformation may play an important role in cyclic peptide design. In addition, scanning electron microscopy, propidium iodide uptake, and membrane permeabilization assays indicated that MPI and the optimized analog C-MPI-1 had membrane-active action modes, indicating that the peptides would not be susceptible to conventional resistance mechanisms. Our study provides additional insight into the influence of intramolecular cyclization at various positions on peptide structure and biological activity. In conclusion, the design and synthesis of cyclic analogs via click chemistry offer a new strategy for the development of stable antimicrobial agents. Copyright (C) 2017 European Peptide Society and John Wiley & Sons, Ltd.

Advancements in loop cyclisation approaches for enhanced pep1de therapeutics for targeting protein-protein interactions

Advancements in Loop Cyclization Approaches for Enhanced Peptide Therapeutics for Targeting Protein-Protein Interactions

New peptide deformylase inhibitors design, synthesis and pharmacokinetic assessment

Designing Cyclic-Constrained Peptides to Inhibit Human Phosphoglycerate Dehydrogenase

Rational design of small-molecule peptidomimetics for three pivotal protein secondary structures

Current Synthetic Approaches to Peptide and Peptidomimetic Cyclization

Stapled peptides for new drug discovery

A Comprehensive Review on Current Advances in Peptide Drug Development and Design

Design and Synthetic Strategies for Helical Peptides.

A Platform of ADAPTive Scaffolds: Development of CDR-H3 -Hairpin Mimics into Covalent Inhibitors of the PD1/PDL1 Immune Checkpoint.

Recent Advances in Peptide Macrocyclization Strategies.

Rational Design of Peptide-Based Inhibitors Disrupting Protein-Protein Interactions

Cyclic Peptide Linker Design and Optimization by Molecular Dynamics Simulations

Biocompatible Strategies for Peptide Macrocyclisation

Disulfide-constrained peptide scaffolds enable a robust peptide-therapeutic discovery platform

Isothiocyanate Enabled Versatile Cyclizations of Phage Dis-played Peptides for the Discovery of Macrocyclic Binders

Precisely Regulated and Efficient Locking of Linear Peptides into Stable Multicyclic Topologies through a One-Pot Reaction.

Research progress in the synthesis and bioactivity of stapled peptide

Directed Disulfide Pairing and Folding of Peptides for the De Novo Development of Multicyclic Peptide Libraries

Intramolecular Cyclization of the Antimicrobial Peptide Polybia-MPI with Triazole Stapling: Influence on Stability and Bioactivity

Therapeutic design of peptide modulators of protein-protein interactions in membranes